Literature DB >> 35287409

Digital Tools for Assessing Disease Severity in Dermatology.

Khushboo H Modasia1, Feroze Kaliyadan2.   

Abstract

Innumerable scoring systems have been introduced to measure the disease severity of various dermatological conditions. The development of such scores has proved to be beneficial to assess disease progression and treatment effectiveness in the context of dermatological research. However, these scoring systems tend to be time consuming, monotonous, and hence often difficult to use during overburdened routine clinical consultations, especially when it is in the form of a paper-based system. Many of the scoring systems are now available in the digital form, such as smart phone apps. This aids to calculate effortlessly and reduces human errors associated with paper-based formats. Various calculators like Psoriasis Area Severity Index calculators, Severity Scoring Of Atopic Dermatitis, and Melasma Area Severity Index have been introduced in the digital format for a quicker, efficient quality of work and uncomplicated data storage. This review highlights and discusses some of the digital tools available at present for severity scoring in dermatology. Copyright:
© 2022 Indian Dermatology Online Journal.

Entities:  

Keywords:  Digital calculators; digitalization; disease severity; scoring systems

Year:  2022        PMID: 35287409      PMCID: PMC8917499          DOI: 10.4103/idoj.idoj_636_21

Source DB:  PubMed          Journal:  Indian Dermatol Online J        ISSN: 2229-5178


Introduction

Dermatology is a field with a growing interplay of digitalization, telehealth, and informatics.[1] The smartphone has become an integral part of our practice—whether it be as an image capture (and storage tool)—both clinical and dermoscopy, teledermatology, or for general applications like drug formularies. This is more so after the beginning of the pandemic. Scoring systems and checklists for diagnostic criteria are an integral part of dermatology practice. Many of these scoring systems and criteria are now available online and as apps.

Scope

Apps for assessing disease severity are useful in routine clinical consultations; come with the advantage of being user friendly, quicker (as compared with the conventional paper-based calculators), and easier for documentation/archiving and linking to patient's electronic health records. These apps range from simple calculators to apps embedded with machine learning (MI)/artificial intelligence (AI), which can have a more advanced role in disease evaluation. The paper-based scoring systems have significant inter-observer and intra-observer errors, are time consuming, and record maintenance is cumbersome. Digitalizing these scoring systems provide advantages like increased productivity and quality, reduced manual errors, easy data storage, and is a win-win situation for both the doctor and the patient as the patients do not have to wait for long durations. Such tools have been a boon to clinical practitioners, academic researchers, post-graduate students, and in remote areas in the context of teledermatology. However, practical usage of the apps needs it to be as intuitive and user friendly as possible. Involving dermatologist in the development and testing processes more effectively is key for this.

Convolutional Neural Network

The utility of such apps can be further enhanced by incorporating AI and ML into them. The concept of convolutional neural network (CNN), a type of deep AI neural network, involves comparison between the similarities and biases of two images and classifies it with its highest accuracy. The work that a CNN does to produce a diagnostic result from an image is similar to how a dermatologist uses their training and knowledge. Diagnosing lesions by a dermatologist generally involves an input image (of a cutaneous lesion) being fed through a processing network (the skills and knowledge of the dermatologist who analyzes it and synthesizes available information) to output a “class” (or diagnosis) or a “probability of classes” (differential diagnosis).[2] One of the early examples of AI applied to scoring systems in dermatology was that of “Eczema area and severity index (EASI) dig” by Tremp et al.,[3] in which the EASI score was established using digital images. This proved to be a time saving tool and also reduced significant inter-observer error. This paved the way for the development of digital apps related to other scoring systems. At present, digital scoring/criteria tools are available for many common conditions, such as psoriasis, eczema (including atopic dermatitis), melasma, hidradenitis suppurvativa, Behcet's disease, systemic lupus erythematosus (SLE), burns, pressure ulcers, and for the dermatology life quality index (DLQI) (summary of common apps and websites is given in Table 1).
Table 1

Summary of common tools available for assessment of disease severity/activity

DiseaseScores calculatedName of app/websiteAvailable platformsFree/paidOther remarks
EczemaSCORADMDAppOnlineFreeOutput as pdf
Atopic DermatitisEASIDermcalculatorOnlineFree-
EczemaEASIEASIscore.comOnlineFree
PsoriasisPASIPasitraining.comAndroidFreeOutput as pdf
MelasmaMASI mMASI MSIMelasma Score calculatorAndroidFree
MelasmaMASIMASI ScoreAndroidFree-
Hidradenitis SuppurativaHS-PGA iHS4 Mod sartorius score Hurley SDK-HS/AIAndroid iOSFreeOutput as pdf
Psoriasis Eczema SclerodermaPASI SCORAD RODNANDermascoreAndroidFreeOutput as pdf
Quality of Life of various conditionsDLQIDLQI: the official appAndroid iOSFreeOutput as pdf
Psoriasis Eczema Nail assessment in psoriasis and psoriatic arthritis Quality of lifePASI EASI and SCORAD NAPPA DLQIDermatoolsAndroid iOSFreeOutput as pdf
Psoriatic arthritisDAPSAMDAppOnlineFreeOutput as pdf
Psoriatic arthritisCASPAR criteriaMDAppOnlineFreeOutput as pdf
TEN/SJSSCORTENMDAppOnlineFreeOutput as pdf
Pressure ulcerBraden scaleMDAppOnlineFreeOutput as pdf
BurnsParkland formula calculatorMDAppOnlineFreeOutput as pdf
Urticaria Psoriasis Psoriatic arthritis Cellulitis Systemic Lupus erythematosusUAS PASI CASPAR ALT70 SLICC criteriaMDcalcOnlineFree-
Behcet Systemic Lupus erythematosusChecklist for Behcet disease SLEDAI SLICC criteriaCalculate by QxMDAndroid iOSFree-
Summary of common tools available for assessment of disease severity/activity

Various Apps and Websites for Scoring Systems in Dermatology

Psoriasis

Psoriasis area severity index (PASI)[45] is currently the gold standard score for the assessment of severity of psoriasis but has the limitation of significant inter-observer variation. There are many PASI calculators available, both online (www.pasitraining.com/calculator; http://pasi.corti.li/) and as mobile app (https://play.google.com/store/apps/details?id = com.thunkable.android.sivasubramaniandeveloper.PASI_Calculator). The PASI calculator is developed in a simple web page which just takes the input of the numerical data provided and holds the superiority of producing the PASI score within no fractions of seconds against the traditional way of PASI calculation. This free online application helps physicians and patients in the computation of the PASI [Figures 1 and 2].
Figure 1

Traditional paper based calculation of PASI

Figure 2

PASI calculator available online (less cumbersome than paper based)

Traditional paper based calculation of PASI PASI calculator available online (less cumbersome than paper based)

Atopic dermatitis

SCORAD (Severity Scoring Of Atopic Dermatitis)[6] developed by the European Task Force on atopic dermatitis in 1993 is the most commonly used scoring system for measuring the severity of atopic dermatitis. The SCORAD calculator by MD app[7] (https://www.mdapp.co/scoring-atopic-dermatitis-scorad-calculator-396) provides a free standardized model for assessing the severity of atopic dermatitis lesions. It uses the same formula as used in a traditional way but minimizing the effort and reducing mathematical errors. Dermcalculator (http://www.dermcalculator.com/easi-professional/) is a webpage which allows easy calculation of EASI in less than 1 min [Figure 3]. EASI score (https://easiscore.com/) helps to calculate EASI in an easier method by displaying pictures of the condition; the patient or the physician needs to tap or select the appropriate current stage and the calculation is done. The data storage with unique identification of each patient is possible as it allows us to enter the patient name or ID along with the age [Figures 4 and 5].
Figure 3

calculation of EASI on Dermcalculator

Figure 4

EASIscore.com

Figure 5

Pictorial representation in EASI score

calculation of EASI on Dermcalculator EASIscore.com Pictorial representation in EASI score

Melasma

Melasma area severity index (MASI) is developed by Kimbrough-Green et al.[8] for the assessment of melasma, in which the Total MASI score is calculated by the following formula: Forehead 0.3 (D+H) A + right malar 0.3 (D+H) A + left malar 0.3 (D+H) A + chin 0.1 (D+H) A Where, D = darkness of melasma, H = homogeneity of hyperpigmentation, A = areas involved. Since the Melasma score calculator is available (https://play.google.com/store/apps/details?id = com.thunkable.android.sivasubramaniandeveloper.Melasma&hl = en_IN&gl = US) freely in android play store, calculating MASI, mMASI (mean MASI), and MSI (Melasma Severity Index) at one click is easy and cumberless. Another application named MASI Score (https://play.google.com/store/apps/details?id = com.radiant.masiscore&hl = en_US&gl = US) by Radiant Nutraceuticals Limited is accessible on android platform which allows us to calculate only MASI score; the only drawback is that the score output has to be saved as screenshot in the form of pdf because print option is not available [Figures 6-8].
Figure 6

MASI Score calculator by Radiant Nutraceuticals

Figure 8

Final score on MASI Score calculator

MASI Score calculator by Radiant Nutraceuticals Data entry in MASI score calculator Final score on MASI Score calculator

Hidradenitis suppurativa

Acne inversa severity index (AISI) is considered to be a new disease severity assessment tool for Hidradenitis Suppurativa[9] and the DK-HS/AI app by Dermavalue is available free on iOS [Figures 9-11]. There is also another app for HS based on the Hurley scale (https://play.google.com/store/apps/details?id = com.everywhereim.HSAppEN&hl = en&gl = US). Using this app, it is possible for the dermatologist to easily categorize individual lesions in the form of abscess, inflammatory/non-inflammatory nodules, papules, pustules, and folliculitis at the respective anatomical sites, and at the end, the app directly displays the calculated HS-PGA (Hidradenitis suppurativa-Physician Global Assessment), iHS4 (International Hidradenitis Suppurativa Severity Score System), Mod sartorius score, and the Hurley Stage which are sent in email. When the data are entered in subsequent visits, it compares with the previous data and highlights the improvement or deterioration of the condition. These data can be directly emailed to the respective physician for record maintenance.
Figure 9

Outlook of App for Hidradenitis suppurativa on iOS

Figure 11

Display of HS-PGA, iHS4, Mod Sartorius score, Hurley stage, and notes reduction or aggravation than the previous data entered

Outlook of App for Hidradenitis suppurativa on iOS Body map for selection of area and marking relevant morphology Display of HS-PGA, iHS4, Mod Sartorius score, Hurley stage, and notes reduction or aggravation than the previous data entered

Quality of Life Indices

The DLQI is a dermatology-specific QOL measure that has been well validated, used in many diseases, and translated into many languages.[10] The dermatological conditions are linked with social relations, daily activities, and the psychological status. This impact is more easily determined by the patient rather than by the physician. It is useful from a physician point of view in considering the effectiveness of the treatment which can be assessed by using QOL scores in addition to physical assessment. There is a specific set of questionnaire usually in the form of hard copy available with the dermatologists but now, when we are in the transition phase from nonelectronic to digitalization, the Cardiff university has launched DLQI: the official app, wherein 10 questions concerning patient's perception of the impact of skin diseases on different aspects of their health-related quality of life over the last week is assessed. It can be used by patients to analyze the burden of the condition and by clinicians for evaluation, monitoring treatment efficacy, and psychological burden. It is available free of cost in android platform (https://play.google.com/store/apps/details?id = uk.ac.cardiff.dlqi&hl = en_IN&gl = US) as well as iOS (https://apps.apple.com/in/app/dlqi-the-official-app/id1576503015). It also lets you compare your previous score and is really like managing your quality of life at your fingertips in the time of less than 2 min [Figure 12].
Figure 12

DLQI app by Cardiff University

DLQI app by Cardiff University

Multiple disease scoring applications

Dermascore is an application which is available on android platforms (https://play.google.com/store/apps/details?id = app.dermascore.android), yet to be launched on iOS. Dermascore lets a clinician calculate PASI, SCORAD, and Rodnan score in 1 application itself. PASI calculation is similar to the PASI calculator, while SCORAD is simplified in this version. The modified Rodnan skin score is a measure of skin thickness and is used as a primary or secondary outcome measure in clinical trials of systemic sclerosis (scleroderma),[11] and the assessment is performed by taking into account 17 sites. This app can be managed by trained dermatologists but will be difficult for nontrained professionals and next to impossible for the patients to use it [Figures 13 and 14.
Figure 13

The DermaScore app which helps calculate PASI, Rodnan, and SCORAD in the same app

Figure 14

The last page presents detailed data entry with time and date

The DermaScore app which helps calculate PASI, Rodnan, and SCORAD in the same app The last page presents detailed data entry with time and date The application “Dermavalue” is a one stop check for all the scoring systems like PASI, EASI, SCORAD, and NAPPA (Nail assessment in psoriasis and psoriatic arthritis). NAPPA is a modular instrument for the assessment of clinical and patient-reported outcomes in nail psoriasis; it has three components: a questionnaire assessing quality of life (NAPPA-QoL), a two-part questionnaire assessing patient-relevant treatment benefits (the Patient Benefit Index, NAPPA-PBI), and a psoriasis Clinical Assessment of Severity (NAPPA-CLIN).[12] DLQI application happens to be very user friendly and time saving for both patients and clinicians. Each score is handled as esore for ePASI* and eSCORAD with the facility of the calculated score to be emailed and saved. There are other parameters like treatment goals and benefits i.e ePBI* or ePAIN questionnaire for the patient's self assessment [Figures 15-17.
Figure 15

Dermavalue displaying all the e-scores

Figure 17

ePSOSAT, eNAPPA and eDLQI scores by Dermavalue app

Dermavalue displaying all the e-scores ePASI, eASI, and eSCORAD by Dermavalue app ePSOSAT, eNAPPA and eDLQI scores by Dermavalue app MD app has a tool for measuring severity of psoriatic arthritis based on Disease Activity index for psoriatic Arthritis[13]—https://www.mdapp.co/disease-activity-in-psoriatic-arthritis-dapsa-calculator-612/. This app is a simple 5-point digital scale for easier calculation. Classification criteria for psoriatic arthritis (CASPAR) has been developed by the same platform (https://www.mdapp.co/caspar-criteria-for-psoriatic-arthritis-calculator-422/). SCORTEN for toxic epidermal necrolysis/Stevens-Johnson syndrome is another area where a quick digital scoring tool helps; MD app has a very simple tool for this purpose too (https://www.mdapp.co/scorten-scale-calculator-420/). Further, MD app has tools for severity scoring of pressure ulcers (Braden scale)—https://www.mdapp.co/braden-scale-for-pressure-ulcers-calculator-387/ and the Parkland calculator for burns—https://www.mdapp.co/parkland-formula-calculator-for-burns-104/ MDcalc (www.mdcalc.com) is another utilitarian website which has a number of user friendly scoring systems. This has unrestricted access on both android and iOS platforms. Dermatology-related scoring systems available on MDcalc include Urticaria Activity Score, PASI, Braden score, CASPAR for psoriatic arthritis (PsA), and ALT-70 score for lower extremity cellulitis. It has a useful systemic steroid dose conversion tool. For systemic lupus, it has both the severity scoring tool, SLEDAI-2K, and the criteria Systemic lupus collaborating clinics (SLICC criteria 2012). “Calculate by QxMD” (https://qxmd.com/calculate/) is available online as well on both android and iOS free of cost. It includes a criteria checklist for Behcet's disease and like MDcalc has the SLEDAI-2k and the SLICC for SLE.

Storage of data, related ethical, and medicolegal aspects

The completed scores can be easily saved and shared as pdf or image files. As of now, the available calculators generally do not include an option to add patient details, so there are no ethical issues involved. However, as and when calculators come, in which the name or patient identification number can be tagged and saved or linked to electronic health records, ethical concerns will have to be addressed. These concerns will be similar to the concerns of using electronic health records on third party platforms. In this situation, health care workers will need to use the same stringent security measures, as for any other patient-related data. The dermatologist can also manually store the scores as pdf or images into folders along with the rest of the patient data like photographs and lab reports. The general principles of storing photographs can be applied here too (tag with patient name, ID number, and date), make backups on at least one hard disc and one cloud storage system. Ensure that access to data is restricted and has appropriate security controls. This would be especially important when the data are part of a research study.

Conclusion

The development of digital severity assessment tools in the form of applications and webpages have proved to not only be time saving (the data entry to score calculation takes about only a minute) and cost-effective but also a user friendly approach for the practicing dermatologist, not just in research contexts but also for routine clinical practice. These apps need more studies for validation, across different populations. The future challenges would be to make these apps cheaper, more accessible, enhance integration of AI/MI into the apps to reduce to a minimum the need for manual entry and also to improve aspects like storage/archiving and security.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  12 in total

Review 1.  10 years experience of the Dermatology Life Quality Index (DLQI).

Authors:  Victoria Lewis; Andrew Y Finlay
Journal:  J Investig Dermatol Symp Proc       Date:  2004-03

2.  The inevitability of change.

Authors:  Rokea A El-Azhary
Journal:  Clin Dermatol       Date:  2018-09-15       Impact factor: 3.541

3.  Application of the DAREA/DAPSA score for assessment of disease activity in psoriatic arthritis.

Authors:  Monika Schoels; Daniel Aletaha; Julia Funovits; Arthur Kavanaugh; Daniel Baker; Josef S Smolen
Journal:  Ann Rheum Dis       Date:  2010-06-04       Impact factor: 19.103

4.  AISI: A New Disease Severity Assessment Tool for Hidradenitis Suppurativa.

Authors:  Andrea Chiricozzi; Sara Faleri; Chiara Franceschini; Raffaele Dante Caposiena Caro; Sergio Chimenti; Luca Bianchi
Journal:  Wounds       Date:  2015-10       Impact factor: 1.546

5.  Nail Assessment in Psoriasis and Psoriatic Arthritis (NAPPA): development and validation of a tool for assessment of nail psoriasis outcomes.

Authors:  M Augustin; C Blome; A Costanzo; E Dauden; C Ferrandiz; G Girolomoni; R Gniadecki; L Iversen; A Menter; K Michaelis-Wittern; A Morita; H Nakagawa; K Reich
Journal:  Br J Dermatol       Date:  2014-03       Impact factor: 9.302

6.  'EASIdig'--a digital tool to document disease activity in atopic dermatitis.

Authors:  Mathias Tremp; Imke Knafla; Günter Burg; Brunello Wüthrich; Peter Schmid-Grendelmeier
Journal:  Dermatology       Date:  2011-08-25       Impact factor: 5.366

7.  Dermatologist-level classification of skin cancer with deep neural networks.

Authors:  Andre Esteva; Brett Kuprel; Roberto A Novoa; Justin Ko; Susan M Swetter; Helen M Blau; Sebastian Thrun
Journal:  Nature       Date:  2017-01-25       Impact factor: 49.962

8.  Standardization of the modified Rodnan skin score for use in clinical trials of systemic sclerosis.

Authors:  Dinesh Khanna; Daniel E Furst; Philip J Clements; Yannick Allanore; Murray Baron; Lazlo Czirjak; Oliver Distler; Ivan Foeldvari; Masataka Kuwana; Marco Matucci-Cerinic; Maureen Mayes; Thomas Medsger; Peter A Merkel; Janet E Pope; James R Seibold; Virginia Steen; Wendy Stevens; Christopher P Denton
Journal:  J Scleroderma Relat Disord       Date:  2017 Jan-Apr

9.  Severity scoring of atopic dermatitis: the SCORAD index. Consensus Report of the European Task Force on Atopic Dermatitis.

Authors: 
Journal:  Dermatology       Date:  1993       Impact factor: 5.366

10.  Topical retinoic acid (tretinoin) for melasma in black patients. A vehicle-controlled clinical trial.

Authors:  C K Kimbrough-Green; C E Griffiths; L J Finkel; T A Hamilton; S M Bulengo-Ransby; C N Ellis; J J Voorhees
Journal:  Arch Dermatol       Date:  1994-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.